Pharmacyclics (PCYC) Prices 2.2M Stock Offering

Pharmacyclics, Inc. (Nasdaq: PCYC) announced the pricing of a previously announced underwritten registered public offering of 2,200,000 shares of its common stock, representing approximately 3.1% of the shares of common stock currently outstanding, at a public offering price of $94.20 per share. All of the shares are being sold by Pharmacyclics. The offering is expected to close on March 13, 2013, subject to customary closing conditions.

J.P. Morgan Securities LLC is acting as sole manager for the offering. Pharmacyclics has granted the underwriter a 30-day option to purchase up to an additional 330,000 shares of common stock to cover over-allotments, if any.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ADARx Pharmaceuticals prices $446.3M IPO at $17 per share
• Amaero postpones U.S. IPO citing adverse market conditions
• Corteva to spin off Vylor as public company on Oct. 1